Post-approval studies (Phase 4)Study completedNCT01419249
What this trial is testing
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Who this might be right for
Idiopathic Growth Hormone DeficiencyTurner Syndrome
Merck KGaA, Darmstadt, Germany 458